September 30, 2009
By:George Koroneos, Online Content & News Editor
Just months on the job and GSK’s new president of North American Pharmaceuticals Deirdre Connelly is already making her presence known. Her latest move—spearheading an initiative that will boost funding to autonomous CME programs and cut commercial medical education programs. Pharm Exec spoke with Connelly to find out more.
 |
September 1, 2009
Brent Saunders, Schering-Plough's president of global consumer healthcare, talks growing role of OTC drugs in Pharma's future.
|
April 1, 2009
"Best Pharma not Big Pharma" is Merck Serono head Elmar Schnee's business philosophy. He tells Pharm Exec Europe how the Swiss-based company aims to achieve that goal, and points out the current political obstacles.
|
March 18, 2009
By:George Koroneos, Online Content & News Editor
Pharm Exec sits down with Kathryn Metcalfe, Pfizer's new vice president of corporate reputation and policy communications to discuss the new position, the perception of pharma among laypeople, and what needs to be done to boost public opinion of the drug industry.
|
February 1, 2009
By:Joanna Breitstein
The world is suffering. But just over the horizon is a new access equation that could speed innovative vaccines to where they're needed most.
|
January 16, 2009
Although stem cell research has sparked controversy for years, Osiris Therapeutics has been flying under the radar for a decade with a revolutionary secret.
|
December 11, 2008
By:George Koroneos, Online Content & News Editor
Pharm Exec talks with James Christian, head of security at Novartis, to learn more about what the company is doing to protect its supply chain and stop counterfeiters
|
December 11, 2008
By:Patrick Clinton
Two years ago, an internal Merck survey revealed that its basic research operation was "every flavor of what you don't want." Today the company is in the midst of implementing a new strategy that groups scientists at sites dedicated to particular clinical areas. VP Kathleen Metters explains why - and how.
|
| 
PharmExec Blog
Follow Us
RSS
Bookstore
The New Health is the fast-morphing world of biopharma: emerging science, changing technology, rising costs, global regulations. The New Health needs an ally. More at www.quintiles.com/newhealth.
What's the best managed pharma? Professor Bill Trombetta of Saint Joseph's University attempts to answer the question in Pharm Exec's Industry Audit.
The most respected annual ranking of top 50 pharmaceutical companies by prescription drug sales... Who's in, who's back, and who's out?
Don't miss this Podcast series commemorating the 20th anniversary of HBA's Woman of the Year Award with interviews spanning two decades of change makers.
Super Reps book trilogy by Dr. Lou Sawaya MD, MBA